Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 11 November 1994:
Vol. 266. no. 5187, pp. 1051 - 1054
DOI: 10.1126/science.7973660
Prev | Table of Contents | Next

Articles

Science, Vol 266, Issue 5187, 1051-1054
Copyright © 1994 by American Association for the Advancement of Science

articles

A potential noninvasive neurobiological test for Alzheimer's disease

LF Scinto, KR Daffner, D Dressler, BI Ransil, D Rentz, S Weintraub, M Mesulam, and H Potter

Laboratory of Eye Movements and Higher Cortical Functions, Brigham and Women's Hospital, MA 02115.

Currently Alzheimer's disease, which affects more than 20 million people worldwide, can only be definitely diagnosed by histological examination of brain tissue obtained at autopsy or biopsy. There is a great need for an early, noninvasive, sensitive, and easily administered diagnostic test of Alzheimer's disease. Here it is reported that patients diagnosed with probable Alzheimer's disease by standard clinical criteria exhibited a marked hypersensitivity in their pupil dilation response to a cholinergic antagonist, tropicamide, placed in their eyes. It was possible to distinguish 18 of 19 individuals (95%) either clinically diagnosed with Alzheimer's disease or classified as suspect Alzheimer's individuals by neuropsychological screening from 30 of 32 normal elderly controls (94%).


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Biomarkers in the Diagnosis of Alzheimer's Disease: Are We Ready?.
T. Sunderland, H. Hampel, M. Takeda, K. T. Putnam, and R. M. Cohen (2006)
J Geriatr Psychiatry Neurol 19, 172-179
   Abstract »    PDF »
Multiple-Level Studies Are Needed to Assess the True Value of Diagnostic Tests for Dementia.
W. A. Van Gool (2006)
Arch Neurol 63, 142-143
   Full Text »    PDF »
Cocaine and Phenylephrine Eye Drop Test for Parkinson Disease.
H. Sawada, K. Yamakawa, H. Yamakado, R. Hosokawa, M. Ohba, K. Miyamoto, T. Kawamura, and S. Shimohama (2005)
JAMA 293, 932-934
   Full Text »    PDF »
Is videopupillography useful in diagnosing Alzheimer's disease?.
J. Verghese, E. Ferrario, M. Molaschi, L. Villa, O. Varetto, C. Bogetto, and R. Nuzzi (1999)
Neurology 52, 673
   Full Text »
Pupil Dilation to Tropicamide Is Not Specific for Alzheimer Disease.
J. H. Growdon, K. Graefe, M. Tennis, D. Hayden, D. Schoenfeld, and S. H. Wray (1997)
Arch Neurol 54, 841-844
   Abstract »    PDF »
Response of the Pupil to Tropicamide Is Not a Reliable Test for Alzheimer Disease.
J. S. FitzSimon, S. C. Waring, E. Kokmen, J. W. McLaren, and R. F. Brubaker (1997)
Arch Neurol 54, 155-159
   Abstract »    PDF »
Cautiousness in testing for Alzheimer's disease.
L.-G. Gunnarsson and C. Lundberg (1995)
American Journal of Alzheimer's Disease and Other Dementias 10, 37-38
   Abstract »    PDF »
Geriatric Medicine.
T. M. Gill and M. E. Tinetti (1995)
JAMA 273, 1684-1686
   Abstract »    PDF »
Neurology.
R. J. Joynt (1995)
JAMA 273, 1695-1697
   Abstract »    PDF »
Ophthalmology.
L. A. Levin (1995)
JAMA 273, 1703-1705
   Abstract »    PDF »
Simple Early Test Eyed for Alzheimer's Disease.
(1995)
Journal Watch Dermatology 1995, 15
   Full Text »
SIMPLE, EARLY TEST IS EYED FOR ALZHEIMER'S DISEASE.
(1994)
Journal Watch (General) 1994, 2
   Full Text »
Possible new test found for Alzheimer's disease.
M Barinaga (1994)
Science 266, 973
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)